U01
/ Tongji University, Shanghai Unicar
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 23, 2025
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
(clinicaltrials.gov)
- P1/2 | N=50 | Recruiting | Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine
New P1/2 trial • B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1